Very good read on $OUST.
A 70%–100% growth rate in 2H seems high, but considering the contribution from Stereolabs, whose revenue is expected to come mainly in 2H, per the CFO, and the ramp-up of Rev8, it’s not impossible.
Adjusted EBITDA breakeven could come as early as Q4.
